Our locations are open for appointments and procedures. See how we're providing safe in-person care and telemedicine visits.

(Nuestras facilidades están abiertas para citas y procedimientos. Vea cómo brindamos atención segura en persona y visitas por medio de telemedicina.)

Learn More (Aprenda Más)
800-TEMPLE-MED Schedule Appointment
back to doctor search


Douglas W. Laske, MD

Douglas W. Laske



about me
about me
  • MD, Columbia University College of Physicians & Surgeons, New York, NY
  • Fellowship, Neuro-Oncology, National Institutes of Health, Rockville, MD
  • Residency, Neurological Surgery, Virginia Commonwealth University Health System, Richmond, VA
Board Certification
  • Neurological Surgery
  • Congress of Neurological Surgeons
  • Fellow, American Association of Neurological Surgeons
  • Pennsylvania Neurosurgical Society
  • Philadelphia County Medical Society
  • Pennsylvania Medical Society
  • Society for Neuro-Oncology
Awards and Honors
  • Fellowship, Brain Tumor Surgery and Treatment, National Institutes of Health
  • Chief, Division of Neurosurgery, Abington Hospital
  • Top Docs, Philadelphia Magazine, 2010-2014
  • America's Top Doctors, Castle Connolly, 2010-2014
  • America's Top Doctors for Cancer, Castle Connolly, 2009-2013
  • Best Doctors in America®, Neurological Surgery, 2015-2016, 2017-2018, 2019-2020

Office Locations

Neurosurgical Associates of Abington

Abington Health Center - Willow Grove

2510 Maryland Road, Suite 185

Willow Grove, PA 19090

Phone: 215-657-5886

Selected Publications

Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients.; Neurosurgery. 2005 Jun.

Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer. Cole, M., Parajuli, S., Laske, D., Goldstein, L., Morrison, T., Mukherjee, A.,Tumelty, K.,Tetzlaff, E.,von Mehren, M.,Inniss, S.; Am J Case Rep. 2014 Jul 22.

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. Weaver, M., Laske, D. W.; J Neurooncol. 2003 Oct.